Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sylvain Simon

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Cancers|April 3, 2021
Anti-Tumor Efficacy of PD-L1 Targeted Alpha-Particle Therapy in a Human Melanoma Xenograft ModelMarisa Capitao, Justine Perrin, Sylvain Simon, et al.
Blood|October 7, 2024
Single-cell analysis of the multiple myeloma microenvironment after γ-secretase inhibition and CAR T-cell therapyDavid G Coffey, Pinar Ataca Atilla, Erden Atilla, et al.
Frontiers in Immunology|May 7, 2024
CARs derived from broadly neutralizing, human monoclonal antibodies identified by single B cell sorting target hepatitis B virus-positive cellsSophia Schreiber, Lisa S Dressler, Eva Loffredo-Verde, et al.
Journal for Immunotherapy of Cancer|February 1, 2020
Increased antitumor efficacy of PD-1-deficient melanoma-specific human lymphocytesLucine Marotte, Sylvain Simon, Virginie Vignard, et al.
Research Square|May 15, 2024
Sensitive bispecific chimeric T cell receptors for cancer therapySylvain Simon, Grace Bugos, Rachel Prins, et al.
Journal for Immunotherapy of Cancer|February 7, 2024
Systemically administered low-affinity HER2 CAR T cells mediate antitumor efficacy without toxicityTamer Basel Shabaneh, Andrew R Stevens, Sylvia M Stull, et al.
Nature Cancer|March 18, 2025
Design of sensitive monospecific and bispecific synthetic chimeric T cell receptors for cancer therapySylvain Simon, Grace Bugos, Rachel Prins, et al.
Journal for Immunotherapy of Cancer|November 14, 2020
PD-1 and TIGIT coexpression identifies a circulating CD8 T cell subset predictive of response to anti-PD-1 therapySylvain Simon, Valentin Voillet, Virginie Vignard, et al.
Cancer Discovery|June 11, 2025
Gut microbiota modulation through Akkermansia spp. supplementation increases CAR-T cell potencyLaura Marcos-Kovandzic, Michele Avagliano, Myriam Ben Khelil, et al.
Immunity|February 14, 2024
Signaling via a CD27-TRAF2-SHP-1 axis during naive T cell activation promotes memory-associated gene regulatory networksCarla A Jaeger-Ruckstuhl, Yun Lo, Elena Fulton, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Cancers|April 3, 2021
Anti-Tumor Efficacy of PD-L1 Targeted Alpha-Particle Therapy in a Human Melanoma Xenograft ModelMarisa Capitao, Justine Perrin, Sylvain Simon, et al.
Blood|October 7, 2024
Single-cell analysis of the multiple myeloma microenvironment after γ-secretase inhibition and CAR T-cell therapyDavid G Coffey, Pinar Ataca Atilla, Erden Atilla, et al.
Frontiers in Immunology|May 7, 2024
CARs derived from broadly neutralizing, human monoclonal antibodies identified by single B cell sorting target hepatitis B virus-positive cellsSophia Schreiber, Lisa S Dressler, Eva Loffredo-Verde, et al.
Journal for Immunotherapy of Cancer|February 1, 2020
Increased antitumor efficacy of PD-1-deficient melanoma-specific human lymphocytesLucine Marotte, Sylvain Simon, Virginie Vignard, et al.
Research Square|May 15, 2024
Sensitive bispecific chimeric T cell receptors for cancer therapySylvain Simon, Grace Bugos, Rachel Prins, et al.
Journal for Immunotherapy of Cancer|February 7, 2024
Systemically administered low-affinity HER2 CAR T cells mediate antitumor efficacy without toxicityTamer Basel Shabaneh, Andrew R Stevens, Sylvia M Stull, et al.
Nature Cancer|March 18, 2025
Design of sensitive monospecific and bispecific synthetic chimeric T cell receptors for cancer therapySylvain Simon, Grace Bugos, Rachel Prins, et al.
Journal for Immunotherapy of Cancer|November 14, 2020
PD-1 and TIGIT coexpression identifies a circulating CD8 T cell subset predictive of response to anti-PD-1 therapySylvain Simon, Valentin Voillet, Virginie Vignard, et al.
Cancer Discovery|June 11, 2025
Gut microbiota modulation through Akkermansia spp. supplementation increases CAR-T cell potencyLaura Marcos-Kovandzic, Michele Avagliano, Myriam Ben Khelil, et al.
Immunity|February 14, 2024
Signaling via a CD27-TRAF2-SHP-1 axis during naive T cell activation promotes memory-associated gene regulatory networksCarla A Jaeger-Ruckstuhl, Yun Lo, Elena Fulton, et al.
Pageof 3